SNORA69: A Potential Drug Target and Biomarker (G26779)

Target Name: SNORA69

NCBI ID: G26779

SNORA69

Other Name(s): Small nucleolar RNA, H/ACA box 69 | small nucleolar RNA, H/ACA box 69 | U69 | RNU69 | U69A

SNORA69: A Potential Drug Target and Biomarker

Small nucleolar RNA (snRNA), also known as H/ACA box 69, is a non-coding RNA molecule that plays a crucial role in various cellular processes, including DNA replication, gene expression, and RNA processing. The H/ACA box 69 is a subunit of the A small nuclear RNA (snRNA) family, which is known to have multiple functions in different cellular contexts. However, the exact function of H/ACA box 69 is not well understood, and its potential role in disease remains unexplored.

Recent studies have identified SNORA69 as a potential drug target and biomarker, which may offer new avenues for the development of therapeutic interventions. In this article, we will explore the biology of SNORA69, its potential drug targets, and its potential as a biomarker for various diseases.

The H/ACA box 69 is a small RNA molecule that is expressed in different cell types and is involved in various cellular processes. It is a part of the A small nuclear RNA (snRNA) family, which includes various subunits, such as H/ACA box 68 and H/ACA box 66. H/ACA box 69 is characterized by a specific open reading frame (ORF) that is composed of 194 amino acid residues.

One of the unique features of H/ACA box 69 is its expression pattern. It is primarily expressed in the cytoplasm of human cells and is not detectable in the nucleus. This is in contrast to other snRNAs, such as H/ACA box 68, which is predominantly expressed in the nucleus. The specific expression pattern of H/ACA box 69 may play a role in its unique function in cellular processes.

Functional characterization of H/ACA box 69 has been limited due to its high degree of homogeneity. However, recent studies have identified that H/ACA box 69 is involved in various cellular processes, including DNA replication, gene expression, and RNA processing.

One of the key functions of H/ACA box 69 is its role in DNA replication. H/ACA box 69 is a component of the R2 complex, which is responsible for the synthesis of DNA in the cytoplasm of human cells. R2 complex consists of various proteins, including DnaC, which is a core protein responsible for the initiation of DNA replication, and snRNA, which is involved in the extension of the replication complex.

In addition to its role in DNA replication, H/ACA box 69 is also involved in gene expression. It has been shown to play a role in the regulation of gene expression by affecting the levels of various RNA species, including mRNA, rRNA, and snRNA. For example, studies have shown that H/ACA box 69 can interact with the protein Skratch, which is involved in the negative regulation of gene expression.

Furthermore, H/ACA box 69 is also involved in the processing of RNA. It has been shown to play a role in the processing of various RNA species, including pre-mRNA, post-mRNA, and microRNA. This may be important for the regulation of gene expression and the regulation of various cellular processes.

Potential drug targets

The potential drug targets for H/ACA box 69 are numerous and varied. Given its involvement in various cellular processes, it is likely that H/ACA box 69 may be a target for a variety of therapeutic interventions. Here are some of the potential drug targets for H/ACA box 69:

1.

Protein Name: Small Nucleolar RNA, H/ACA Box 69

The "SNORA69 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA69 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets